Length of hospital stay · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Adverse events Assessed by investigators or reported by parents · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 1 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 2 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Clinical severity score (post‐treatment) at day 3 · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Annual hospitalisation rates · infants up to 24 months of age with acute bronchiolitis
Nebulised hypertonic saline may leads to lower rate of hospitalisation compared with nebulised 0.9% saline (low certainty).
1 finding from 1 review
Hospital readmission · infants up to 24 months of age with acute bronchiolitis
Nebulised hypertonic saline showed no clear difference in rate of readmission to hospital compared with nebulised 0.9% saline (low certainty).
1 finding from 1 review
Number of days to resolution of symptoms and signs (wheezing) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Number of days to resolution of symptoms and signs (cough) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Number of days to resolution of symptoms and signs(pulmonary moist crackles) · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Mean days to wellness Patient reports · patients with acute upper respiratory tract infections
1 finding from 1 review
Antibiotic usage Patient‐reported usage · patients with acute upper respiratory tract infections
It is very uncertain whether normal saline plus standard treatment changes antibiotic usage Patient‐reported usage compared with standard treatment alone (very low certainty).
1 finding from 1 review
Sore throat · patients with acute upper respiratory tract infections
1 finding from 1 review
Adverse events · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate changes duration of hospital stay compared with hypertonic saline (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured at 0 to 24 hoursafter treatment · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured 25 to 48 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with hypertonic saline (very low certainty).
1 finding from 1 review
Hospital re‐admission within 30 days of discharge · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to recovery · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found